Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US Homeland Security Sees Rapid Growth In Device Cybersecurity Vulnerability Reports

Executive Summary

A center inside the US Department of Homeland Security has seen a massive spike in the number of potential medical device cybersecurity vulnerabilities that it has responded to in the past year. The government says it reflects better collaboration and disclosure policies in industry.

You may also be interested in...



Lack Of Funding Stalls Major US FDA Cybersecurity Initiative

A public-private partnership board long touted by top US FDA officials to help address cybersecurity threats has hit a funding wall. The agency received less than half of what it asked for in the FY 2019 budget for its digital efforts, including its cybersecurity strategy, leading it to make some tough choices.

Gaps Remain In US FDA's Response Procedures For Cybersecurity Events, OIG Says

FDA's policies and procedures do not adequately address how to handle post-market device cybersecurity events and the agency had not adequately tested its ability to respond to emergencies arising from such events, US HHS' investigative arm says. But the top cybersecurity official at FDA's device center says OIG's report is "incomplete and inaccurate."

Abbott Issues New Cybersecurity Patch For Cardiac Devices

After Abbott recently settled a case against short-seller Muddy Waters, the company has put out a second cybersecurity patch for certain St. Jude radio-frequency enabled cardiac devices to stop potential hackers from harming patients.

Related Content

Topics

UsernamePublicRestriction

Register

MT122772

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel